Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Hematologic Malignancies
•
Leukemia
•
Hematology
What induction would you choose for a healthy 65 year old with prior chemo/RT for H&N cancer 2 years ago, now with FLT3-ITD+ (0.25) and inv(16) AML?
Related Questions
What is your approach to re-challenging BTK inhibitors for a patient who has had intolerance to several different agents?
What is the preferred approach for an AYA patient with VHR B-ALL with iAMP21 mutation with an isolated early CNS relapse?
Would you offer intensive CNS prophylaxis to Ph negative B-ALL patients who have possible mandibular nerve involvement on MRI face?
How should one approach an incidentally found T-cell gene arrangement?
How long do you continue ATRA during induction in high risk acute promyelocytic leukemia?
What is the role of post-transplant FLT3 inhibition given the results of BMT-CTN 1506 (MORPHO)?
In what situations do you use G-CSF for patients undergoing allogeneic HSCT to facilitate engraftment?
How would you manage an elderly patient with mild pancytopenia who refuses bone marrow biopsy and whose flow cytometry is suggestive of CMML/MDS?
For AML patients, when do you stop antiinfective agents?
With the recent approval of quizartinib, what is your preferred first-line FLT3 inhibitor in combination with chemotherapy for a fit AML patient with a FLT3-ITD mutation?
